HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ulka N Vaishampayan Selected Research

GSK2636771

10/2021A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ulka N Vaishampayan Research Topics

Disease

26Neoplasms (Cancer)
02/2022 - 12/2005
25Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 02/2007
17Prostatic Neoplasms (Prostate Cancer)
12/2021 - 12/2005
15Carcinoma (Carcinomatosis)
12/2021 - 10/2005
13Neoplasm Metastasis (Metastasis)
12/2021 - 08/2006
6Disease Progression
01/2021 - 07/2009
5Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 08/2015
3Pain (Aches)
09/2014 - 07/2009
2Melanoma (Melanoma, Malignant)
01/2021 - 11/2007
2Fatigue
01/2017 - 09/2014
2Nausea
01/2017 - 11/2007
2Hand-Foot Syndrome
03/2016 - 07/2010
2Kidney Neoplasms (Kidney Cancer)
01/2016 - 02/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2021
1Adenocarcinoma
01/2021
1Urologic Neoplasms (Urological Cancer)
10/2020
1Clear-cell metastatic renal cell carcinoma
01/2020
1Pathologic Complete Response
01/2019
1Malignant Mesothelioma
01/2019
1Mesothelioma
01/2019
1Hemorrhage
11/2017
1Limbal Stem Cell Deficiency
01/2017
1Photophobia (Light Sensitivity)
01/2017

Drug/Important Bio-Agent (IBA)

10Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2005
8PlatinumIBA
12/2021 - 10/2005
7Biomarkers (Surrogate Marker)IBA
10/2021 - 07/2009
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 09/2012
5AndrogensIBA
12/2021 - 04/2013
5EverolimusFDA Link
10/2021 - 03/2016
5Sunitinib (Sutent)FDA Link
10/2021 - 03/2016
4Prostate-Specific Antigen (Semenogelase)IBA
12/2021 - 07/2009
4cabozantinibIBA
01/2021 - 02/2013
4Hormones (Hormone)IBA
01/2021 - 12/2005
3enzalutamideIBA
10/2021 - 05/2015
3olaparibIBA
03/2021 - 05/2017
3Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2021 - 05/2015
3Bevacizumab (Avastin)FDA Link
12/2017 - 11/2013
3Docetaxel (Taxotere)FDA Link
01/2014 - 07/2009
2Abiraterone AcetateIBA
12/2021 - 11/2017
2Androgen Receptors (Androgen Receptor)IBA
10/2021 - 05/2015
2angiokinesIBA
06/2021 - 01/2021
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021 - 03/2016
2AntigensIBA
01/2021 - 01/2017
2Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2018
2Circulating Tumor DNAIBA
10/2020 - 01/2018
2Cell-Free Nucleic AcidsIBA
10/2020 - 01/2018
2IpilimumabIBA
12/2019 - 05/2017
2NivolumabIBA
12/2019 - 05/2015
2Therapeutic UsesIBA
10/2019 - 01/2017
2Tyrosine Kinase InhibitorsIBA
01/2019 - 02/2013
2B7-H1 AntigenIBA
01/2017 - 02/2015
2GemcitabineFDA Link
08/2015 - 09/2014
2Interleukin-2 (IL2)IBA
02/2015 - 11/2013
2satraplatin (JM 216)IBA
01/2014 - 11/2009
2InterferonsIBA
11/2007 - 02/2007
2Thalidomide (Thalomid)FDA Link
11/2007 - 02/2007
1trametinibIBA
02/2022
1erdafitinibIBA
12/2021
1antiarrhythmic peptide (AAP)IBA
12/2021
1acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamideFDA Link
12/2021
1Testosterone (Sustanon)FDA Link
12/2021
1sacituzumab govitecanIBA
12/2021
1enfortumab vedotinIBA
12/2021
1Prednisone (Sone)FDA LinkGeneric
12/2021
1GSK2636771IBA
10/2021
1Recombinant DNA (Recombinant DNA Research)IBA
03/2021
1ChromatinIBA
02/2021
1cediranib (AZD2171)IBA
01/2021
1bicalutamide (Casodex)FDA LinkGeneric
01/2021
1Peptides (Polypeptides)IBA
01/2021
1VaccinesIBA
01/2021
1lenvatinibIBA
01/2021
1LigandsIBA
01/2019
1Pemetrexed (MTA)FDA Link
01/2019
1AntibodiesIBA
01/2019
1avelumabIBA
01/2019
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1carotuximabIBA
12/2017
1clevudineIBA
12/2017
1ThymineIBA
12/2017
1Zoledronic Acid (Zometa)FDA Link
12/2017
1Alanine Transaminase (SGPT)IBA
11/2017
1Immune Checkpoint InhibitorsIBA
05/2017
1Immunoconjugates (Immunoconjugate)IBA
01/2017
1monomethylauristatin FIBA
01/2017
1PF-06263507IBA
01/2017

Therapy/Procedure

34Therapeutics
12/2021 - 10/2005
13Drug Therapy (Chemotherapy)
12/2021 - 12/2005
6Nephrectomy
11/2019 - 08/2006
4Castration
10/2021 - 02/2013
4Adjuvant Chemotherapy
12/2020 - 01/2018
3Neoadjuvant Therapy
10/2020 - 08/2015
2Radiotherapy
12/2021 - 05/2017
2Cystectomy
12/2020 - 08/2015
1Combination Drug Therapy (Combination Chemotherapy)
12/2021
1Prostatectomy (Retropubic Prostatectomy)
12/2021
1Immunotherapy
01/2021
1Urinary Diversion (Ileal Conduit)
12/2020
1Precision Medicine
05/2017